Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: the DIVA study
| Autor: | Lucy Rowell, B. Bonvoisin, Robert R. Recker, Edward Czerwiński, Louis George Ste-Marie, Daiva Masanauskaite, Bente L. Langdahl, Dieter Felsenberg |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
medicine.medical_specialty
Histology Physiology Endocrinology Diabetes and Metabolism Osteoporosis Urology Placebo Ibandronic acid Bone and Bones Drug Administration Schedule Bone remodeling Double-Blind Method Bone Density Biopsy medicine Humans Ibandronic Acid Osteoporosis Postmenopausal Aged Bone mineral medicine.diagnostic_test Diphosphonates business.industry Osteoid Middle Aged medicine.disease Surgery Apposition Injections Intravenous Female Bone Remodeling business medicine.drug |
| Zdroj: | Recker, R R, Ste-Marie, L-G, Langdahl, B, Czerwinski, E, Bonvoisin, B, Masanauskaite, D, Rowell, L & Felsenberg, D 2010, ' Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: the DIVA study ', Bone, vol. 46, no. 3, pp. 660-5 . https://doi.org/10.1016/j.bone.2009.11.004 |
| ISSN: | 1873-2763 |
| Popis: | Udgivelsesdato: 2010-Mar In the Dosing IntraVenous Administration (DIVA) study, IV ibandronate injections (15-30 s duration) provided significantly greater gains in bone mineral density than daily oral ibandronate (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect